My Dividend Growth Portfolio: Selling Bio-Pharma And Buying More Big-Tech
alengo It’s been a little while since I’ve published a portfolio review, but in recent months, I’ve continued to take strides reshaping my portfolio into my desired long-term form, so I wanted to take some time this week to provide an update for everyone. In short, I’ve been intensely focused on accumulating shares of blue…